DLHC
Fiscal year ends September Quarters are offset from the calendar — Q1 is Oct–Dec

DLH Holdings Corp. provides health and national security readiness solutions to U.S. federal government customers through digital transformation, cyber security, science research and development, and systems engineering and integration. The company serves agencies including the Department of Health and Human Services, the Department of Veterans Affairs, and the Department of Defense, with key clients such as the National Institutes of Health, the Center for Disease Control and Prevention, and the Defense Health Agency. Services include IT modernization, cloud enablement, big data analytics, clinical trials research, epidemiology studies, and C5ISR systems engineering. DLH operates primarily as a prime contractor, delivering pharmacy and logistics services under the VA's Consolidated Mail Outpatient Pharmacy program and supporting military health systems. The company leverages artificial intelligence, machine learning, and zero trust architecture to enhance operational efficiency and cybersecurity resilience for civilian and military missions.

Summarised from the company's own disclosures, fiscal year ended Dec 2025

Industry Information Technology Services Homepage dlhcorp.com
Sector Technology IR page investors.dlhcorp.com
Tags
cyber security, digital transformation, clinical research, systems engineering, data analytics, cloud computing, federal government contracts, health informatics, c5isr, pharmacy logistics, Consolidated Mail Outpatient Pharmacy, NHLBI, NIH, CDC, DHA, MRDC, SkillBridge
Press page dlhcorp.com/newsroom

Metrics

Valuation  
Market cap $ 53.624M
Market cap (USD) $ 53.624M
P/E -2.48
PEG —
P/BV 0.57
P/S 0.21
P/OCF 3.86
P/FCF 3.59
Dividend yield —
Turnover / mcap —
Returns  
ROE 1.2%
ROI 0.57%
ROIC 5.4%
Profit margin 0.40%
Growth  
Revenue growing No
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) -61.2%
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) No
Debt/Equity 135.4%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 9
Quality score -5.9%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000
Revenue 344.497M 395.937M 375.872M 395.173M 246.094M 209.185M 160.391M 133.236M — — — — — — 41.923M 40.874M 46.021M 73.285M 66.882M 74.968M 55.804M 37.288M 79.82M 649.727M 649.727M 447.743M
Net profit 1.362M 7.397M 1.461M 23.288M 10.145M 7.114M 5.324M 1.836M 3.288M 3.384M 8.728M 5.357M -159K -2.026M -4.32M -5.807M -4.355M 1.146M -4.693M -13.247M -2.489M -4.079M 3.075M 1.348M 1.424M 951K
Free cash flow 22.975M 26.53M 30.408M 371K 45.562M 19.299M 17.634M 13.423M 5.46M 5.542M 1.841M 1.652M 1.796M -2.85M -1.024M -2.438M -2.159M 4.431M -1.621M 8.513M -2.182M -1.212M -1.734M 3.282M 3.348M 3.356M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000
Share price 5.65 9.36 11.67 12.27 12.3 7.25 4.46 5.76 6.48 4.69 2.85 1.94 1.24 1 — — — — — — — — — — — —
Price performance 12m -0.4 -0.2 -0.05 -0 0.7 0.62 -0.22 -0.11 0.38 0.65 0.47 0.56 0.24 — — — — — — — — — — — — —

Filed figures

Figure Sep 2016 Sep 2017 Sep 2018 Sep 2019 Sep 2020 Sep 2021 Sep 2022 Sep 2023 Sep 2024 Sep 2025
Balance sheet detail
Trade receivables (USD) 6.64M 11.9M 10.3M 23.2M 32.5M 33.4M 40.5M 59.1M 49.8M 38.4M
↳ YoY growth +102.0% +79.5% -13.7% +125.9% +40.1% +2.8% +21.1% +46.0% -15.7% -23.0%
↳ 5y CAGR -9.8% -1.8% -3.0% +13.4% +58.2% +38.2% +27.7% +41.9% +16.5% +3.4%
Borrowings, current (USD) — — 0.00 0.00 6.73M 0.00 0.00 17.2M 12.1M 8.07M
Borrowings, non-current (USD) — — 6.96M 53.6M 60.5M 44.6M 20.4M 155M 137M 120M
Lease liabilities (USD) — — — 18M 23.7M 21.6M 18.7M 19.4M 15.4M 16.9M
Cash and deposits (USD) 3.43M 4.93M 6.36M 1.79M 1.36M 24.1M 228,000 215,000 342,000 125,000
Intangible assets (USD) 42.3M 15.1M 13.4M 41.2M 52.6M 47.5M 40.9M 125M 108M 91.9M
Right-of-use assets (USD) — — — 17.4M 22.4M 19.9M 16.9M 9.66M 6.68M 8.76M
Net debt (borrowings + leases - cash) (USD) — — 603,000 69.9M 89.6M 42.2M 38.9M 191M 164M 145M
Cash flow detail
Operating cash flow (USD) 6.04M 6.52M 14.1M 18M 19.5M 45.7M 1.24M 31M 27.4M 23.2M
Purchases of property, plant and equipment (USD) -498,000 -1.06M -654,000 -405,000 -152,000 -103,000 -872,000 -625,000 -836,000 -241,000
Change in receivables (cash effect) (USD) -3.35M -5.27M 1.63M 617,000 -5.41M -906,000 -7.05M 6.85M 9.27M 11.5M
Change in payables (cash effect) (USD) 5.11M 3.95M 1.31M 5.26M 7.19M 4.14M -5.86M -75,000 -4.41M -6.04M
Share buybacks (cash effect) (USD) — — — 0.00 -211,000 0.00 — — — —
Interest paid (cash effect) (USD) -454,000 -883,000 -800,000 -1.5M -2.81M -2.94M -1.53M -14.2M -16M -13.5M
Income taxes paid (cash effect) (USD) -124,000 -337,000 -876,000 -543,000 -917,000 -936,000 -9.28M -5.6M -3.26M -2.05M
Share-based compensation (USD) 466,000 662,000 1.38M — — — 2.61M 1.92M 1.9M 1.46M
Operating cash flow before change in receivables (USD) 9.39M 11.8M 12.4M 17.4M 24.9M 46.6M 8.29M 24.2M 18.1M 11.8M
Free cash flow (OCF - PPE - intangibles) (USD) 5.54M 5.46M 13.4M 17.6M 19.3M 45.6M 371,000 30.4M 26.5M 23M
Reported Dec 9, 2016 Dec 12, 2017 Aug 5, 2019 Dec 7, 2020 Dec 7, 2020 Jan 31, 2022 Dec 6, 2023 Dec 6, 2023 Dec 4, 2024 Dec 10, 2025

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

October 13, 2026/in 2026-PR

ATLANTA, October 13 – DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of digital, engineering, and scientific solutions for health and defense missions, today published an open letter to shareholders from President and CEO Kathryn JohnBull marking approximately 100 days since the Company’s leadership transition. The letter highlights initial actions taken by management to pursue achievable growth opportunities, simplify the company’s operating structure, and empower leaders for success.

“While much hard work remains, we are encouraged by early progress and believe the actions taken position DLH to deliver stronger long-term performance,” Ms. JohnBull states in the letter.

The full CEO letter to Shareholders is available now on DLH’s investor relations website .

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:

This document may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or DLH`s future financial performance. Any statements that refer to expectations, projections or other characterizations of future events or circumstances or that are not statements of historical fact (including without limitation statements to the effect that the Company or its management “believes”, “expects”, “anticipates”, “plans”, “intends” and similar expressions) should be considered forward-looking statements that involve risks and uncertainties which could cause actual events or DLH’s actual results to differ materially from those indicated by the forward-looking statements. Forward-looking statements in this document include, among others, statements regarding expected contract performance, future task order value, and anticipated operational benefits. These statements reflect our belief and assumptions as to future events that may not prove to be accurate. Our actual results may differ materially from such forward-looking statements due to a variety of factors, including: the failure to achieve the anticipated benefits of any future acquisition (including anticipated future financial operating performance and results); the inability to retain employees and customers; contract awards in connection with re-competes for present business and/or competition for new business; our ability to manage our debt obligations; compliance with bank financial and other covenants; changes in client budgetary priorities; government contract procurement (such as bid and award protests, small business set asides, loss of work due to organizational conflicts of interest, etc.) and termination risks; significant delays or reductions in appropriations for our programs and broader changes in U.S. government funding and spending patterns; legislation that amends or changes discretionary spending levels or budget priorities; legal, regulatory, and political changes from the federal government that could result in economic uncertainty; the impact of inflation and higher interest rates; and other risks described in our SEC filings. For a discussion of such risks and uncertainties which could cause actual results to differ from those contained in the forward-looking statements, see “Risk Factors” in the Company’s periodic reports filed with the SEC, including our Annual Report on Form 10-K for the fiscal year ended September 30, 2025, as well as interim quarterly filings thereafter. The forward-looking statements contained herein are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our industry and business. Such forward-looking statements are made as of the date hereof and may become outdated over time. The Company does not assume any responsibility for updating forward-looking statements.

Share this entry

About DLH

DLH enhances public health and national security readiness missions through science, technology, cyber, and engineering solutions and services. Our experts solve some of most complex and critical missions faced by federal customers, leveraging digital transformation, artificial intelligence, advanced analytics, cloud-based applications, telehealth systems, and more. With over 3,200 employees dedicated to the idea that “Your Mission is Our Passion,” DLH brings a unique combination of government sector experience, proven methodology, and unwavering commitment to innovative solutions to improve the lives of millions.

https://www.dlhcorp.com/wp-content/uploads/2026/10/DLH-Web-Newsroom-Shareholder-Letter-400-214.jpg 214 400 Noah Wasserman https://www.dlhcorp.com/wp-content/uploads/2020/01/dlh-logo.png Noah Wasserman2026-10-13 08:30:172026-10-13 05:48:00DLH Publishes CEO Letter to Shareholders Highlighting “First 100 Days”

Atlanta Headquarters

  • 3565 Piedmont Road, NE Building 3, Suite 700
    Atlanta, GA 30305
  • 770-554-3545

National Capital Region Headquarters

  • 6720B Rockledge Drive
    Suite 777
    Bethesda, MD 20817
  • 770-554-3545

Quick Links

© Copyright 2026 - DLH | Web Design by M16 Marketing

Link to: DLH Wins $2 Million NIH Data Governance Pilot Task Order Link to: DLH Wins $2 Million NIH Data Governance Pilot Task Order DLH Wins $2 Million NIH Data Governance Pilot Task Order

Scroll to top Scroll to top Scroll to top

DLH Wins $2 Million NIH Data Governance Pilot Task Order Bull 1 Bear 0 Order/contract

October 5, 2026

PDF Version

ATLANTA, Oct. 05, 2026 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of digital, engineering, and scientific solutions for health and defense missions, today announced that it has been awarded a task order to design, develop, and pilot a data governance framework for secure access to controlled biomedical research data by the National Institutes of Health (“NIH”).

Under this task order, DLH will serve as a technical advisor to harmonize NIH and federal data policies and integrate governance workflows across biomedical data platforms, piloting a data management approach within the National Heart, Lung, and Blood Institute (“NHLBI”) and at least one other NIH Institute or Center which could serve as a roadmap for NIH-wide adoption.​ DLH will incorporate security, privacy, data rights, and artificial intelligence (“AI”) governance requirements where applicable, and collect performance metrics related to usability, compliance, interoperability, and stakeholder satisfaction.

“This award expands our role as a technical and strategic advisor to NIH and brings together DLH’s expertise in biomedical research, data governance, and secure digital solutions,” said Brooke Pierce, President of DLH’s Health business group. “We believe this work will strengthen our foundation for pursuing future enterprise-scale modernization opportunities as NIH evaluates broader adoption of the framework.”

This task order represents new work for DLH and has a total value of $2 million over an eighteen-month period of performance.

About DLH

DLH (NASDAQ: DLHC) enhances technology, public health, and cyber security readiness missions through science, technology, cyber, and engineering solutions and services. Our experts solve some of the most complex and critical missions faced by federal customers, leveraging digital transformation, artificial intelligence, advanced analytics, cloud-based applications, telehealth systems, and more. With a world-class workforce dedicated to the idea that “Your Mission is Our Passion,” DLH brings a unique combination of government sector experience, proven methodology, and unwavering commitment to innovative solutions to improve the lives of millions. For more information, visit www.DLHcorp.com.

September 28, 2026/in 2026-PR

ATLANTA, September 28, 2026 – DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of digital, engineering, and scientific solutions for health and defense missions, today announced that it has been awarded a task order valued at up to $19.1 million to provide risk management framework (“RMF”) and cybersecurity operations support services to the National Institutes of Health (“NIH”) Center for Information Technology (“CIT”). CIT provides the NIH community with a secure and reliable IT infrastructure in support of its mission-critical research activities.

This task order is new work to DLH, and has a potential value of $19.1 million inclusive of all option periods. The base period and multiple options aggregate to a three-year period of performance. DLH joined with other leading technology services providers to form a well-positioned delivery team.

Under the task order, DLH will provide integrated cybersecurity services across NIH’s enterprise environment, including security assessment and authorization, vulnerability management, incident response, cloud security, security architecture, privacy, compliance, training, and program management. The work will support compliance with federal cybersecurity requirements and advance NIH priorities related to zero trust, cloud modernization, automation, and the responsible use of artificial intelligence.

“This award expands DLH’s support for NIH as the organization strengthens resilience, reduces operational risk, and maintains mission continuity in an evolving cyber landscape,” said DLH President and CEO Kathryn JohnBull. “This award aligns with our strategy to grow technology-powered solutions in core markets.”

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:

This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or DLH`s future financial performance. Any statements that refer to expectations, projections or other characterizations of future events or circumstances or that are not statements of historical fact (including without limitation statements to the effect that the Company or its management “believes”, “expects”, “anticipates”, “plans”, “intends” and similar expressions) should be considered forward-looking statements that involve risks and uncertainties which could cause actual events or DLH’s actual results to differ materially from those indicated by the forward-looking statements. Forward-looking statements in this release include, among others, statements regarding expected contract performance, future task order value, and anticipated operational benefits. These statements reflect our belief and assumptions as to future events that may not prove to be accurate. Our actual results may differ materially from such forward-looking statements due to a variety of factors, including: the failure to achieve the anticipated benefits of any future acquisition (including anticipated future financial operating performance and results); the inability to retain employees and customers; contract awards in connection with re-competes for present business and/or competition for new business; our ability to manage our debt obligations; compliance with bank financial and other covenants; changes in client budgetary priorities; government contract procurement (such as bid and award protests, small business set asides, loss of work due to organizational conflicts of interest, etc.) and termination risks; significant delays or reductions in appropriations for our programs and broader changes in U.S. government funding and spending patterns; legislation that amends or changes discretionary spending levels or budget priorities; legal, regulatory, and political changes from the federal government that could result in economic uncertainty; the impact of inflation and higher interest rates; and other risks described in our SEC filings. For a discussion of such risks and uncertainties which could cause actual results to differ from those contained in the forward-looking statements, see “Risk Factors” in the Company’s periodic reports filed with the SEC, including our Annual Report on Form 10-K for the fiscal year ended September 30, 2025, as well as interim quarterly filings thereafter. The forward-looking statements contained herein are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our industry and business. Such forward-looking statements are made as of the date hereof and may become outdated over time. The Company does not assume any responsibility for updating forward-looking statements.

Share this entry

About DLH

DLH enhances public health and national security readiness missions through science, technology, cyber, and engineering solutions and services. Our experts solve some of most complex and critical missions faced by federal customers, leveraging digital transformation, artificial intelligence, advanced analytics, cloud-based applications, telehealth systems, and more. With over 3,200 employees dedicated to the idea that “Your Mission is Our Passion,” DLH brings a unique combination of government sector experience, proven methodology, and unwavering commitment to innovative solutions to improve the lives of millions.

https://www.dlhcorp.com/wp-content/uploads/2026/09/DLH-Web-NIH-RMF-Cyber-400-214.jpg 214 400 Noah Wasserman https://www.dlhcorp.com/wp-content/uploads/2020/01/dlh-logo.png Noah Wasserman2026-09-28 08:30:212026-09-28 10:28:50DLH Awarded New NIH Cybersecurity Operations Task Order Valued at Up to $19.1 Million

Atlanta Headquarters

  • 3565 Piedmont Road, NE Building 3, Suite 700
    Atlanta, GA 30305
  • 770-554-3545

National Capital Region Headquarters

  • 6720B Rockledge Drive
    Suite 777
    Bethesda, MD 20817
  • 770-554-3545

Quick Links

© Copyright 2026 - DLH | Web Design by M16 Marketing

Link to: DLH Secures Follow-On NHLBI IT Services Award Valued at Up to $43.7 Million Link to: DLH Secures Follow-On NHLBI IT Services Award Valued at Up to $43.7 Million DLH Secures Follow-On NHLBI IT Services Award Valued at Up to $43.7 Million Link to: DLH Wins $2 Million NIH Data Governance Pilot Task Order Link to: DLH Wins $2 Million NIH Data Governance Pilot Task Order DLH Wins $2 Million NIH Data Governance Pilot Task Order

Scroll to top Scroll to top Scroll to top

Prompts

DLH Holdings Corp. (ticker DLHC), listed in United States.

Company History

Date Change Detail
Jun 27, 2012 Renamed TEAMSTAFF INC → DLH HOLDINGS CORP.

ETFs Holding DLH Holdings Corp.

ETF Weight in ETF Shares Market value As of
DFAT 0.00% 77,560 $ 271.46K Nov 12, 2026
DFSV 0.00% 27,134 $ 94.969K Nov 12, 2026
DFSU 0.00% 2,108 $ 7,378.00 Nov 12, 2026
DXUV 0.00% 4,597 $ 16.09K Nov 12, 2026
DFAS 0.00% 15,103 $ 52.861K Nov 12, 2026
DCOR 0.00% 20,082 $ 70.287K Nov 12, 2026
DFAC 0.00% 21,039 $ 73.637K Nov 12, 2026
AVSC 0.00% 3,723 $ 11.169K Nov 16, 2026